Zócalo Health | $15,000,000 | (Apr 24, 2026)
Rilian | $17,500,000 | (Apr 24, 2026)
BAND | $17,000,000 | (Apr 24, 2026)
Certified by Founder
Lodge
Outrun Therapeutics
start up
United Kingdom
- Dundee, Scotland
- 19/04/2024
- Seed
- $10,000,000
Outrun Therapeutics is unlocking the therapeutic potential of protein stabilisation by E3 Ligase inhibition for the treatment of cancer and other diseases.
- Industry Biotechnology Research
- Website https://outruntx.com/
- LinkedIn https://www.linkedin.com/company/outrun-therapeutics/
Related People
Carolyn PorterFounder
United Kingdom -
Greater Oxford Area
25 years of leadership experience, including in the spin-out arena, having led the formation of 16 companies raising £52M cumulatively in seed financing while at Oxford University. Held Board positions in several biotech companies and formerly held Business Development roles in big pharma (Novartis) and big biotech(Chiron).
Specialties: Key skills include business development, deal negotiation and execution, strategic, market and business analysis, people management and project management.
Brev.io | $3,300,000 | (Apr 24, 2026)
Maxed | $850,000 | (Apr 24, 2026)
Omni | $120,000,000 | (Apr 24, 2026)
VREY | $3,859,432 | (Apr 24, 2026)
Astor (YC S25) | $5,000,000 | (Apr 24, 2026)
QMatter | $1,200,000 | (Apr 24, 2026)
Almanac Health | $10,000,000 | (Apr 24, 2026)
Petual | $20,000,000 | (Apr 24, 2026)
C-Infinity | $16,000,000 | (Apr 23, 2026)